Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

682 trials with published results (15%)

Research Maturity

3031 completed trials (66% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.2%

191 terminated out of 4602 trials

Success Rate

94.1%

+7.6% vs benchmark

Late-Stage Pipeline

22%

1034 trials in Phase 3/4

Results Transparency

23%

682 of 3031 completed with results

Key Signals

682 with results94% success191 terminated

Data Visualizations

Phase Distribution

3,612Total
Not Applicable (2003)
Early P 1 (36)
P 1 (281)
P 2 (258)
P 3 (457)
P 4 (577)

Trial Status

Completed3,031
Unknown530
Recruiting364
Terminated191
Not Yet Recruiting162
Active Not Recruiting137

Trial Success Rate

94.1%

Benchmark: 86.5%

Based on 3031 completed trials

Clinical Trials (4602)

Showing 20 of 20 trials
NCT07181109Phase 3Recruiting

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

NCT07363343Not ApplicableRecruitingPrimary

Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study

NCT06402968Recruiting

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

NCT05138601Not ApplicableActive Not RecruitingPrimary

Remote Monitoring and Virtual Collaborative Care For Hypertension Control to Prevent Cognitive Decline Phase II

NCT05183763Not ApplicableRecruitingPrimary

Medication Adherence Program

NCT07644364Phase 1Not Yet Recruiting

HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension

NCT06545461Not ApplicableCompleted

Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes

NCT06046924Not ApplicableCompleted

Dietary Acid Reduction and Progression of Chronic Kidney Disease

NCT07553442Phase 2RecruitingPrimary

A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran

NCT05655936Not ApplicableActive Not Recruiting

Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial

NCT02439775Not ApplicableCompletedPrimary

SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System

NCT05121337Not ApplicableCompleted

Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension

NCT05512143Not ApplicableCompleted

TMS for PTSD and Blood Pressure

NCT06689930Not ApplicableRecruiting

Community-based Implementation of Adapted STAC

NCT07534501Not ApplicableRecruitingPrimary

'Eat Well' Produce Prescription RCT

NCT03374215Recruiting

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

NCT07025109Not ApplicableActive Not Recruiting

Assessing Peer Support for Physical Activity in Women With HIV and Hypertension

NCT04021355Not ApplicableCompleted

Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African Americans

NCT05979168Not ApplicableRecruitingPrimary

Effectiveness and Adoption of the TelTex4BP Intervention Among Adults With Hypertension in Nepal

NCT04675593Not ApplicableCompleted

Using mHealth to Improve Adherence and Reduce Blood Pressure in Individuals With Hypertension and Mood Disorders

Scroll to load more

Research Network

Activity Timeline